Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Food Effect Study of AG120 in Healthy Subjects
A Phase 1, Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of Food On AG-120 Pharmacokinetics Following Single Oral Dose Administration To Healthy Subjects
Status: Enrolling
Updated:  11/28/2016
Clinical Research Facility
mi
from
Madison, WI
Food Effect Study of AG120 in Healthy Subjects
A Phase 1, Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of Food On AG-120 Pharmacokinetics Following Single Oral Dose Administration To Healthy Subjects
Status: Enrolling
Updated: 11/28/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
Dose Proportionality of TFV-DP in Mucosal Tissue, and Endogenous Nucleotide Quantification, After a Single Dose of GS-7340 in Women
Status: Enrolling
Updated:  11/29/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
Dose Proportionality of TFV-DP in Mucosal Tissue, and Endogenous Nucleotide Quantification, After a Single Dose of GS-7340 in Women
Status: Enrolling
Updated: 11/29/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
Status: Enrolling
Updated:  11/30/2016
University of Connecticut Health Center, Division of Orthodontics
mi
from
Farmington, CT
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
Status: Enrolling
Updated: 11/30/2016
University of Connecticut Health Center, Division of Orthodontics
mi
from
Farmington, CT
Click here to add this to my saved trials
Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
The Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
Status: Enrolling
Updated:  12/1/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
The Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
Status: Enrolling
Updated: 12/1/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/1000 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 2 x 500 mg]) Co-administered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated:  12/1/2016
Clinical Research Facility
mi
from
Tempe, AZ
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/1000 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 2 x 500 mg]) Co-administered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated: 12/1/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Endophenotype for Alcohol Misuse in Healthy Minority Populations
Defining an Endophenotype for Alcohol Misuse: A Focus On Minority Populations
Status: Enrolling
Updated:  12/1/2016
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Endophenotype for Alcohol Misuse in Healthy Minority Populations
Defining an Endophenotype for Alcohol Misuse: A Focus On Minority Populations
Status: Enrolling
Updated: 12/1/2016
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated:  12/5/2016
Clinical Research Facility
mi
from
Tempe, AZ
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated: 12/5/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
Role of Exercise and Low-Dose Rapamycin on Age-Associated Impairments in Older Adults With Coronary Artery Disease: Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
Status: Enrolling
Updated:  12/6/2016
Mayo Clinic in Rochester and Mayo Health System sites in Austin and Albert Lea, Minnesota
mi
from
Rochester, MN
Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
Role of Exercise and Low-Dose Rapamycin on Age-Associated Impairments in Older Adults With Coronary Artery Disease: Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
Status: Enrolling
Updated: 12/6/2016
Mayo Clinic in Rochester and Mayo Health System sites in Austin and Albert Lea, Minnesota
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
La Jolla, CA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Lansing, MI
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Neptune, NJ
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Charlotte, NC
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Duncansville, PA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated:  12/15/2016
mi
from
Berlin,
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Status: Enrolling
Updated: 12/15/2016
mi
from
Berlin,
Click here to add this to my saved trials
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Lesinurad/Allopurinol Fixed Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets and the Effect of Food on the Pharmacokinetics of Lesinurad/Allopurinol Fixed Dose Combination Tablets in Healthy Adult Male Subjects
Status: Enrolling
Updated:  12/15/2016
Clinical Research Facility
mi
from
Austin, TX
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Lesinurad/Allopurinol Fixed Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets and the Effect of Food on the Pharmacokinetics of Lesinurad/Allopurinol Fixed Dose Combination Tablets in Healthy Adult Male Subjects
Status: Enrolling
Updated: 12/15/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06648671 In Healthy Adults
Status: Enrolling
Updated:  12/19/2016
Pfizer New Haven Clinical Research Unit
mi
from
New Haven, CT
An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06648671 In Healthy Adults
Status: Enrolling
Updated: 12/19/2016
Pfizer New Haven Clinical Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
Exploratory Study in Healthy Volunteers to Define Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
Status: Enrolling
Updated:  12/20/2016
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania
mi
from
Philadelphia, PA
Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
Exploratory Study in Healthy Volunteers to Define Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
Status: Enrolling
Updated: 12/20/2016
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers
Status: Enrolling
Updated:  12/20/2016
Wcct Global, Llc
mi
from
Cypress, CA
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers
Status: Enrolling
Updated: 12/20/2016
Wcct Global, Llc
mi
from
Cypress, CA
Click here to add this to my saved trials
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
Status: Enrolling
Updated:  12/20/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/20/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated:  12/22/2016
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated: 12/22/2016
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated:  12/22/2016
University of Iowa - Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated: 12/22/2016
University of Iowa - Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated:  12/22/2016
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated: 12/22/2016
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Intra-Arterial Microdosing: Proof-of-Concept in Humans
Intra-Arterial Microdosing: Proof-of-Concept in Humans
Status: Enrolling
Updated:  12/22/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Intra-Arterial Microdosing: Proof-of-Concept in Humans
Intra-Arterial Microdosing: Proof-of-Concept in Humans
Status: Enrolling
Updated: 12/22/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans: An Evaluation of a New Clinical Lot of Escherichia Coli (E. Coli Group O 113:H10:K Negative) Endotoxin in Healthy Volunteers
Status: Enrolling
Updated:  12/22/2016
Duke Clinical Research Unit (DCRU)
mi
from
Durham, NC
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans: An Evaluation of a New Clinical Lot of Escherichia Coli (E. Coli Group O 113:H10:K Negative) Endotoxin in Healthy Volunteers
Status: Enrolling
Updated: 12/22/2016
Duke Clinical Research Unit (DCRU)
mi
from
Durham, NC
Click here to add this to my saved trials
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.
Status: Enrolling
Updated:  12/28/2016
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.
Status: Enrolling
Updated: 12/28/2016
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Diindolylmethane in Healthy Volunteers
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Study of Nutritional-Grade, Absorption-Enhanced DIM (BR-DIM)
Status: Enrolling
Updated:  12/28/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Diindolylmethane in Healthy Volunteers
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Study of Nutritional-Grade, Absorption-Enhanced DIM (BR-DIM)
Status: Enrolling
Updated: 12/28/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Bowman-Birk Inhibitor Concentrate in Healthy Men
Phase I Single Dose Safety and Pharmacokinetic Study of a New Formulation of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age
Status: Enrolling
Updated:  12/28/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Bowman-Birk Inhibitor Concentrate in Healthy Men
Phase I Single Dose Safety and Pharmacokinetic Study of a New Formulation of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age
Status: Enrolling
Updated: 12/28/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diindolylmethane in Preventing Cancer in Healthy Volunteers
Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-indolylmethane (DIM)
Status: Enrolling
Updated:  12/28/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Diindolylmethane in Preventing Cancer in Healthy Volunteers
Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-indolylmethane (DIM)
Status: Enrolling
Updated: 12/28/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
aeRobic Exercise and Cognitive Health
Aerobic Exercise for Alzheimer's Disease Prevention in At-Risk Middle-Aged Adults
Status: Enrolling
Updated:  12/29/2016
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
aeRobic Exercise and Cognitive Health
Aerobic Exercise for Alzheimer's Disease Prevention in At-Risk Middle-Aged Adults
Status: Enrolling
Updated: 12/29/2016
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Robotic Assessment of Lower Extremity Motor Learning
Robotic Assessment of Lower Extremity
Status: Enrolling
Updated:  1/3/2017
Spaulding Rehabilitation Hospital Boston
mi
from
Boston, MA
Robotic Assessment of Lower Extremity Motor Learning
Robotic Assessment of Lower Extremity
Status: Enrolling
Updated: 1/3/2017
Spaulding Rehabilitation Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults
A Comparative, Randomized, Single-Dose, 2-Way Crossover Pharmacokinetic Comparability Study of CB-839 Administered as Capsule and Tablet Formulations in Healthy Adult Subjects
Status: Enrolling
Updated:  1/3/2017
Algorithme Pharma USA, LLC
mi
from
Fargo, ND
A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults
A Comparative, Randomized, Single-Dose, 2-Way Crossover Pharmacokinetic Comparability Study of CB-839 Administered as Capsule and Tablet Formulations in Healthy Adult Subjects
Status: Enrolling
Updated: 1/3/2017
Algorithme Pharma USA, LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
Tongue Motor Recruitment During Exercise
Genioglossus Motor Recruitment During Swallowing and Expiratory Loading Exercises
Status: Enrolling
Updated:  1/4/2017
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Tongue Motor Recruitment During Exercise
Genioglossus Motor Recruitment During Swallowing and Expiratory Loading Exercises
Status: Enrolling
Updated: 1/4/2017
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  1/5/2017
Parexel Early Phase Unit at Glendale
mi
from
Glendale, CA
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 1/5/2017
Parexel Early Phase Unit at Glendale
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  1/5/2017
CRI Lifetree
mi
from
Marlton, NJ
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 1/5/2017
CRI Lifetree
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  1/5/2017
PRA Health Sciences
mi
from
Salt Lake City, UT
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 1/5/2017
PRA Health Sciences
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  1/5/2017
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
mi
from
Kobe,
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 1/5/2017
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
mi
from
Kobe,
Click here to add this to my saved trials
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers
Bioequivalence of Two Biphasic Insulin Aspart 30 (NovoLog® Mix 70/30) Formulations (Current and New Formulation With Glycerol): A Randomized, Double-Blind, Two-Period Crossover Study in Healthy Volunteers
Status: Enrolling
Updated:  1/5/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers
Bioequivalence of Two Biphasic Insulin Aspart 30 (NovoLog® Mix 70/30) Formulations (Current and New Formulation With Glycerol): A Randomized, Double-Blind, Two-Period Crossover Study in Healthy Volunteers
Status: Enrolling
Updated: 1/5/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Open Label Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Open Label Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
A Phase I, Randomized Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
A Phase I, Randomized Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
A Phase I, Randomized Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
Status: Enrolling
Updated:  1/10/2017
Tufts Medical Center
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
A Phase I, Randomized Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
Status: Enrolling
Updated: 1/10/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
A Phase 1, Randomized, Placebo-Controlled, Observer-Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous and Homologous Prime-Boost Regimens Using MVA-BN-Filo® and Ad26.ZEBOV Administered in Different Doses, Sequences and Schedules in Healthy Adult Subjects
Status: Enrolling
Updated:  1/11/2017
Clinical Research Facility
mi
from
Rockville, MD
A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
A Phase 1, Randomized, Placebo-Controlled, Observer-Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous and Homologous Prime-Boost Regimens Using MVA-BN-Filo® and Ad26.ZEBOV Administered in Different Doses, Sequences and Schedules in Healthy Adult Subjects
Status: Enrolling
Updated: 1/11/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Dose Response to Recombinant Factor VIIa When Administered for Bleed
Recombinant Activated Factor VII (rFVIIa/NovoSeven) Dose Response Trial in Healthy Volunteers: A Double-Blind, Placebo-Controlled, Cross-over, Dose-Escalation Trial to Investigate the Dose Response to REcombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers
Status: Enrolling
Updated:  1/11/2017
Novo Nordisk Investigational Site
mi
from
Overland Park, KA
Dose Response to Recombinant Factor VIIa When Administered for Bleed
Recombinant Activated Factor VII (rFVIIa/NovoSeven) Dose Response Trial in Healthy Volunteers: A Double-Blind, Placebo-Controlled, Cross-over, Dose-Escalation Trial to Investigate the Dose Response to REcombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers
Status: Enrolling
Updated: 1/11/2017
Novo Nordisk Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)
Status: Enrolling
Updated:  1/12/2017
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)
Status: Enrolling
Updated: 1/12/2017
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males
A Randomized, Single-Dose, 3-Way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Caplet Formulation Compared With the IX 01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Caplet Formulation, in Healthy Male Subjects
Status: Enrolling
Updated:  1/12/2017
Worldwide Clinical Trials Early Phase Services
mi
from
San Antonio, TX
Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males
A Randomized, Single-Dose, 3-Way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Caplet Formulation Compared With the IX 01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Caplet Formulation, in Healthy Male Subjects
Status: Enrolling
Updated: 1/12/2017
Worldwide Clinical Trials Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials